Gelonghui, March 14 | According to the latest equity disclosure data on the Stock Exchange, on March 7, 2024, Pharmaceutical Biotech (02269.HK) obtained JPMorgan Chase & Co. to increase its holding of 6.574,600 shares at an average price of HK$17.4077 per share, involving approximately HK$114 million.
After the increase in holdings, JPMorgan Chase & Co.'s latest number of good positions was 261,196,599 shares, and the holding ratio increased from 5.97% to 6.13%.
